214 related articles for article (PubMed ID: 36372519)
41. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.
Jia Y; Wen X; Gong Y; Wang X
Eur J Med Chem; 2020 Aug; 200():112359. PubMed ID: 32531682
[TBL] [Abstract][Full Text] [Related]
42. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs.
Zhang X; Rakesh KP; Shantharam CS; Manukumar HM; Asiri AM; Marwani HM; Qin HL
Bioorg Med Chem; 2018 Jan; 26(2):340-355. PubMed ID: 29269253
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
[TBL] [Abstract][Full Text] [Related]
44. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
[TBL] [Abstract][Full Text] [Related]
45. Indole Alkaloids, Synthetic Dimers and Hybrids with Potential In Vivo Anticancer Activity.
Song F; Bian Y; Liu J; Li Z; Zhao L; Fang J; Lai Y; Zhou M
Curr Top Med Chem; 2021; 21(5):377-403. PubMed ID: 32901583
[TBL] [Abstract][Full Text] [Related]
46. The anti-breast cancer potential of indole/isatin hybrids.
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300402. PubMed ID: 37650315
[TBL] [Abstract][Full Text] [Related]
47. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.
Nepali K; Sharma S; Sharma M; Bedi PM; Dhar KL
Eur J Med Chem; 2014 Apr; 77():422-87. PubMed ID: 24685980
[TBL] [Abstract][Full Text] [Related]
48. Triazine-benzimidazole hybrids: anticancer activity, DNA interaction and dihydrofolate reductase inhibitors.
Singla P; Luxami V; Paul K
Bioorg Med Chem; 2015 Apr; 23(8):1691-700. PubMed ID: 25792141
[TBL] [Abstract][Full Text] [Related]
49. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors.
Megally Abdo NY; Milad Mohareb R; Halim PA
Bioorg Chem; 2020 Apr; 97():103667. PubMed ID: 32087416
[TBL] [Abstract][Full Text] [Related]
50. Diverse Synthetic Approaches and Biological Activities of Lucrative Pyrimidine- Triazine Hybrid Derivatives: A Review.
Asgaonkar K; Patil S; Pradhan K; Tanksali S; Jain J
Curr Org Synth; 2023; 20(7):734-757. PubMed ID: 36125826
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
52. 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities.
Singh S; Mandal MK; Masih A; Saha A; Ghosh SK; Bhat HR; Singh UP
Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000363. PubMed ID: 33760298
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and molecular modeling studies of new series of antitumor 1,2,4-triazines with potential c-Met kinase inhibitory activity.
El-Wakil MH; Ashour HM; Saudi MN; Hassan AM; Labouta IM
Bioorg Chem; 2018 Feb; 76():154-165. PubMed ID: 29175587
[TBL] [Abstract][Full Text] [Related]
54. 1,2,3-Triazole hybrids as anticancer agents: A review.
Alam MM
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100158. PubMed ID: 34559414
[TBL] [Abstract][Full Text] [Related]
55. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications.
Kushwaha N; Sharma CS
Mini Rev Med Chem; 2020; 20(20):2104-2122. PubMed ID: 32727324
[TBL] [Abstract][Full Text] [Related]
56. Anticancer activity of bisindole alkaloids derived from natural sources and synthetic bisindole hybrids.
Zhang Y; Hu C
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000092. PubMed ID: 32468606
[TBL] [Abstract][Full Text] [Related]
57. Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships.
Zhang B
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900240. PubMed ID: 31797422
[TBL] [Abstract][Full Text] [Related]
58. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
59. Investigations of antiproliferative and antioxidant activity of β-lactam morpholino-1,3,5-triazine hybrids.
Ranjbari S; Behzadi M; Sepehri S; Dadkhah Aseman M; Jarrahpour A; Mohkam M; Ghasemi Y; Reza Akbarizadeh A; Kianpour S; Atioğlu Z; Özdemir N; Akkurt M; Masoud Nabavizadeh S; Turos E
Bioorg Med Chem; 2020 Apr; 28(8):115408. PubMed ID: 32165076
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Liu H; Long S; Rakesh KP; Zha GF
Eur J Med Chem; 2020 Jan; 185():111804. PubMed ID: 31675510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
